The global market for Parkinson's Disease Therapeutics was valued at US$ 2641 million in the year 2024 and is projected to reach a revised size of US$ 3948 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Parkinson's Disease Therapeutics Market

Parkinson"s disease (PD), or simply Parkinson"s, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson"s disease dementia becomes common in advanced stages of the disease.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease Therapeutics.

The Parkinson's Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parkinson's Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Parkinson's Disease Therapeutics Market Report

Report Metric	Details
Report Name	Parkinson's Disease Therapeutics Market
Accounted market size in year	US$ 2641 million
Forecasted market size in 2031	US$ 3948 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Sinemet-CR Trastal Madopar COMT Inhibitor Other
Segment by Application	Under 40 Years Old 40-65 Years Old Above 65 Years Old
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Roche, H.Lundbeck, Bausch Health, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Desitin Arzneimittel, Endo Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Parkinson's Disease Therapeutics Market growing?

Ans: The Parkinson's Disease Therapeutics Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Parkinson's Disease Therapeutics Market size in 2031?

Ans: The Parkinson's Disease Therapeutics Market size in 2031 will be US$ 3948 million.

Who are the main players in the Parkinson's Disease Therapeutics Market report?

Ans: The main players in the Parkinson's Disease Therapeutics Market are Merck, Akorn, GSK, Novartis, Boehringer Ingelheim, Teva Pharmaceutical, Abbvie, Kyowa Hakko Kirin Pharma, Astellas Pharma, Roche, H.Lundbeck, Bausch Health, Apokyn, Orion, Stada Arzneimittel, US WorldMeds, Desitin Arzneimittel, Endo Pharmaceuticals

What are the Application segmentation covered in the Parkinson's Disease Therapeutics Market report?

Ans: The Applications covered in the Parkinson's Disease Therapeutics Market report are Under 40 Years Old, 40-65 Years Old, Above 65 Years Old

What are the Type segmentation covered in the Parkinson's Disease Therapeutics Market report?

Ans: The Types covered in the Parkinson's Disease Therapeutics Market report are Sinemet-CR, Trastal, Madopar, COMT Inhibitor, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Sinemet-CR

1.2.3 Trastal

1.2.4 Madopar

1.2.5 COMT Inhibitor

1.2.6 Other

1.3 Market by Application

1.3.1 Global Parkinson's Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Under 40 Years Old

1.3.3 40-65 Years Old

1.3.4 Above 65 Years Old

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Parkinson's Disease Therapeutics Market Perspective (2020-2031)

2.2 Global Parkinson's Disease Therapeutics Growth Trends by Region

2.2.1 Global Parkinson's Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Parkinson's Disease Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Parkinson's Disease Therapeutics Market Dynamics

2.3.1 Parkinson's Disease Therapeutics Industry Trends

2.3.2 Parkinson's Disease Therapeutics Market Drivers

2.3.3 Parkinson's Disease Therapeutics Market Challenges

2.3.4 Parkinson's Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue

3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Parkinson's Disease Therapeutics Revenue

3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio

3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2024

3.5 Global Key Players of Parkinson's Disease Therapeutics Head office and Area Served

3.6 Global Key Players of Parkinson's Disease Therapeutics, Product and Application

3.7 Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson's Disease Therapeutics Breakdown Data by Type

4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2026-2031)

5 Parkinson's Disease Therapeutics Breakdown Data by Application

5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Parkinson's Disease Therapeutics Market Size (2020-2031)

6.2 North America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025)

6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Parkinson's Disease Therapeutics Market Size (2020-2031)

7.2 Europe Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025)

7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Parkinson's Disease Therapeutics Market Size (2020-2031)

9.2 Latin America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Parkinson's Disease Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Parkinson's Disease Therapeutics Introduction

11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.1.5 Merck Recent Development

11.2 Akorn

11.2.1 Akorn Company Details

11.2.2 Akorn Business Overview

11.2.3 Akorn Parkinson's Disease Therapeutics Introduction

11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.2.5 Akorn Recent Development

11.3 GSK

11.3.1 GSK Company Details

11.3.2 GSK Business Overview

11.3.3 GSK Parkinson's Disease Therapeutics Introduction

11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.3.5 GSK Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Parkinson's Disease Therapeutics Introduction

11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction

11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Teva Pharmaceutical

11.6.1 Teva Pharmaceutical Company Details

11.6.2 Teva Pharmaceutical Business Overview

11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction

11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.6.5 Teva Pharmaceutical Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Details

11.7.2 Abbvie Business Overview

11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction

11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.7.5 Abbvie Recent Development

11.8 Kyowa Hakko Kirin Pharma

11.8.1 Kyowa Hakko Kirin Pharma Company Details

11.8.2 Kyowa Hakko Kirin Pharma Business Overview

11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction

11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.8.5 Kyowa Hakko Kirin Pharma Recent Development

11.9 Astellas Pharma

11.9.1 Astellas Pharma Company Details

11.9.2 Astellas Pharma Business Overview

11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction

11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.9.5 Astellas Pharma Recent Development

11.10 Roche

11.10.1 Roche Company Details

11.10.2 Roche Business Overview

11.10.3 Roche Parkinson's Disease Therapeutics Introduction

11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.10.5 Roche Recent Development

11.11 H.Lundbeck

11.11.1 H.Lundbeck Company Details

11.11.2 H.Lundbeck Business Overview

11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction

11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.11.5 H.Lundbeck Recent Development

11.12 Bausch Health

11.12.1 Bausch Health Company Details

11.12.2 Bausch Health Business Overview

11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction

11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.12.5 Bausch Health Recent Development

11.13 Apokyn

11.13.1 Apokyn Company Details

11.13.2 Apokyn Business Overview

11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction

11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.13.5 Apokyn Recent Development

11.14 Orion

11.14.1 Orion Company Details

11.14.2 Orion Business Overview

11.14.3 Orion Parkinson's Disease Therapeutics Introduction

11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.14.5 Orion Recent Development

11.15 Stada Arzneimittel

11.15.1 Stada Arzneimittel Company Details

11.15.2 Stada Arzneimittel Business Overview

11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction

11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.15.5 Stada Arzneimittel Recent Development

11.16 US WorldMeds

11.16.1 US WorldMeds Company Details

11.16.2 US WorldMeds Business Overview

11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction

11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.16.5 US WorldMeds Recent Development

11.17 Desitin Arzneimittel

11.17.1 Desitin Arzneimittel Company Details

11.17.2 Desitin Arzneimittel Business Overview

11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction

11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.17.5 Desitin Arzneimittel Recent Development

11.18 Endo Pharmaceuticals

11.18.1 Endo Pharmaceuticals Company Details

11.18.2 Endo Pharmaceuticals Business Overview

11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction

11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2020-2025)

11.18.5 Endo Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kyowa Hakko Kirin Pharma

List of Tables

Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Sinemet-CR

Table 3. Key Players of Trastal

Table 4. Key Players of Madopar

Table 5. Key Players of COMT Inhibitor

Table 6. Key Players of Other

Table 7. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Parkinson's Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Parkinson's Disease Therapeutics Market Share by Region (2020-2025)

Table 11. Global Parkinson's Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Parkinson's Disease Therapeutics Market Share by Region (2026-2031)

Table 13. Parkinson's Disease Therapeutics Market Trends

Table 14. Parkinson's Disease Therapeutics Market Drivers

Table 15. Parkinson's Disease Therapeutics Market Challenges

Table 16. Parkinson's Disease Therapeutics Market Restraints

Table 17. Global Parkinson's Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Parkinson's Disease Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2024)

Table 20. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Parkinson's Disease Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Parkinson's Disease Therapeutics, Product and Application

Table 24. Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Parkinson's Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Parkinson's Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Merck Company Details

Table 50. Merck Business Overview

Table 51. Merck Parkinson's Disease Therapeutics Product

Table 52. Merck Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Merck Recent Development

Table 54. Akorn Company Details

Table 55. Akorn Business Overview

Table 56. Akorn Parkinson's Disease Therapeutics Product

Table 57. Akorn Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Akorn Recent Development

Table 59. GSK Company Details

Table 60. GSK Business Overview

Table 61. GSK Parkinson's Disease Therapeutics Product

Table 62. GSK Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 63. GSK Recent Development

Table 64. Novartis Company Details

Table 65. Novartis Business Overview

Table 66. Novartis Parkinson's Disease Therapeutics Product

Table 67. Novartis Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Novartis Recent Development

Table 69. Boehringer Ingelheim Company Details

Table 70. Boehringer Ingelheim Business Overview

Table 71. Boehringer Ingelheim Parkinson's Disease Therapeutics Product

Table 72. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Boehringer Ingelheim Recent Development

Table 74. Teva Pharmaceutical Company Details

Table 75. Teva Pharmaceutical Business Overview

Table 76. Teva Pharmaceutical Parkinson's Disease Therapeutics Product

Table 77. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 78. Teva Pharmaceutical Recent Development

Table 79. Abbvie Company Details

Table 80. Abbvie Business Overview

Table 81. Abbvie Parkinson's Disease Therapeutics Product

Table 82. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Abbvie Recent Development

Table 84. Kyowa Hakko Kirin Pharma Company Details

Table 85. Kyowa Hakko Kirin Pharma Business Overview

Table 86. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product

Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Kyowa Hakko Kirin Pharma Recent Development

Table 89. Astellas Pharma Company Details

Table 90. Astellas Pharma Business Overview

Table 91. Astellas Pharma Parkinson's Disease Therapeutics Product

Table 92. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Astellas Pharma Recent Development

Table 94. Roche Company Details

Table 95. Roche Business Overview

Table 96. Roche Parkinson's Disease Therapeutics Product

Table 97. Roche Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 98. Roche Recent Development

Table 99. H.Lundbeck Company Details

Table 100. H.Lundbeck Business Overview

Table 101. H.Lundbeck Parkinson's Disease Therapeutics Product

Table 102. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 103. H.Lundbeck Recent Development

Table 104. Bausch Health Company Details

Table 105. Bausch Health Business Overview

Table 106. Bausch Health Parkinson's Disease Therapeutics Product

Table 107. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 108. Bausch Health Recent Development

Table 109. Apokyn Company Details

Table 110. Apokyn Business Overview

Table 111. Apokyn Parkinson's Disease Therapeutics Product

Table 112. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 113. Apokyn Recent Development

Table 114. Orion Company Details

Table 115. Orion Business Overview

Table 116. Orion Parkinson's Disease Therapeutics Product

Table 117. Orion Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 118. Orion Recent Development

Table 119. Stada Arzneimittel Company Details

Table 120. Stada Arzneimittel Business Overview

Table 121. Stada Arzneimittel Parkinson's Disease Therapeutics Product

Table 122. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 123. Stada Arzneimittel Recent Development

Table 124. US WorldMeds Company Details

Table 125. US WorldMeds Business Overview

Table 126. US WorldMeds Parkinson's Disease Therapeutics Product

Table 127. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 128. US WorldMeds Recent Development

Table 129. Desitin Arzneimittel Company Details

Table 130. Desitin Arzneimittel Business Overview

Table 131. Desitin Arzneimittel Parkinson's Disease Therapeutics Product

Table 132. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 133. Desitin Arzneimittel Recent Development

Table 134. Endo Pharmaceuticals Company Details

Table 135. Endo Pharmaceuticals Business Overview

Table 136. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product

Table 137. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)

Table 138. Endo Pharmaceuticals Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Parkinson's Disease Therapeutics Picture

Figure 2. Global Parkinson's Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Parkinson's Disease Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Sinemet-CR Features

Figure 5. Trastal Features

Figure 6. Madopar Features

Figure 7. COMT Inhibitor Features

Figure 8. Other Features

Figure 9. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Parkinson's Disease Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Under 40 Years Old Case Studies

Figure 12. 40-65 Years Old Case Studies

Figure 13. Above 65 Years Old Case Studies

Figure 14. Parkinson's Disease Therapeutics Report Years Considered

Figure 15. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Parkinson's Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Parkinson's Disease Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Parkinson's Disease Therapeutics Market Share by Players in 2024

Figure 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2024

Figure 21. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Parkinson's Disease Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Parkinson's Disease Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2020-2031)

Figure 35. China Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Parkinson's Disease Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 51. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 52. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 54. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 55. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 56. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 57. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 58. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 59. Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 60. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 61. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 62. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 63. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 64. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 65. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 66. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Alzheimers and Parkinsons Diseases Market Insights Forecast to 2030

Global Anti Parkinson s Disease Drugs Market Research Report 2024

Global Parkinson s Disease PD Drugs Market Research Report 2024

Global Neurodegenerative Disease Market Insights Forecast to 2030

Global Parkinson Disease Drug Market Insights Forecast to 2030

Global Parkinsons Disease Drug Market Insights Forecast to 2030

Central Nervous System CNS Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030

Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Parkinson Drugs Market Insights Forecast to 2030

Global Parkinson s Disease Monitoring Device Market Research Report 2024

Global Alzheimer Treatment Drug Market Research Report 2025

Global Oral Antiparkinsonian Drugs Market Research Report 2024

Global Alzheimer s Disease Drug Market Insights Forecast to 2030

Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030

Global Alzheimer s Disease Treatments Market Research Report 2024

Global Neurodegenerative Disease Treatment Market Research Report 2024

Global Deep Brain Stimulation in Parkinson s Disease Market Research Report 2024

Global Oral Parkinson s Disease Medications Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions